temozolomide has been researched along with acetazolamide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carta, F; Dubois, LJ; Lambin, P; Niemans, R; Parvathaneni, NK; Pastorekova, S; Supuran, CT; van Gisbergen, MW; van Kuijk, SJA; Vullo, D; Winum, JY; Yaromina, A | 1 |
| Bua, S; Kopecka, J; Mujumdar, P; Poulsen, SA; Riganti, C; Supuran, CT | 1 |
| Banik, NL; Das, A; Ray, SK | 1 |
| Amiri, A; Gillard, JW; Le, PU; Machkalyan, G; Maysinger, D; Moquin, A; Petrecca, K; Yoganathan, N | 1 |
| Bomal, E; Choi, J; Kakkar, A; Maysinger, D; Moquin, A; Na, L | 1 |
| Borghetto, V; Costanzo, E; Di Bella, G | 1 |
| Farag, VE; Sy, JC; Wood, CM | 1 |
1 review(s) available for temozolomide and acetazolamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for temozolomide and acetazolamide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
Topics: Animals; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Dogs; Drug Design; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Madin Darby Canine Kidney Cells | 2017 |
Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Survival; Drug Design; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Mice; Mice, Nude; Protein Isoforms; Structure-Activity Relationship; Temozolomide; Transplantation, Heterologous; Tumor Cells, Cultured | 2019 |
Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells.
Topics: Acetazolamide; Apoptosis; Aquaporin 1; Brain Edema; Brain Neoplasms; Calpain; Carbonic Anhydrases; Caspases; Cell Line, Tumor; Dacarbazine; Dexamethasone; Drug Interactions; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Inflammation; Mitochondria; Neoplasm Proteins; NF-kappa B; RNA, Messenger; RNA, Neoplasm; Temozolomide; Vascular Endothelial Growth Factor A | 2008 |
Inhibition of carbonic anhydrase IX in glioblastoma multiforme.
Topics: Acetazolamide; Antineoplastic Agents; Brain Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dacarbazine; Drug Carriers; Glioblastoma; Humans; Micelles; Spheroids, Cellular; Temozolomide; Time Factors; Tumor Cells, Cultured | 2016 |
Telodendrimers for Physical Encapsulation and Covalent Linking of Individual or Combined Therapeutics.
Topics: Acetazolamide; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Survival; Dacarbazine; Dendrimers; Drug Delivery Systems; Glioblastoma; Humans; Lactates; Micelles; Polyesters; Polyethylene Glycols; Quercetin; Spheroids, Cellular; Temozolomide | 2017 |
A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness.
Topics: Acetazolamide; Antioxidants; Brain Neoplasms; Ditiocarb; Glioblastoma; Humans; Hydroxyurea; Melatonin; Temozolomide; Vitamins | 2021 |
Modeling of the effect of cerebrospinal fluid flow modulation on locally delivered drugs in the brain.
Topics: Acetazolamide; Animals; Brain; Cerebrospinal Fluid; Delayed-Action Preparations; Extracellular Fluid; Rats; Temozolomide | 2022 |